StonvexLoading…
StonvexCore line items from RES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2019 2019-03-31 | Annual 2018 2018-12-31 | Q3 2018 2018-09-30 | Q2 2018 2018-06-30 |
|---|---|---|---|---|---|
Revenue | $478.24M | $334.66M | $1.72B | $1.34B | $904.26M |
Operating Income | Not available | $-2.16M | $210.03M | $190.38M | $135.83M |
Net Income | Not available | $-739.00K | $175.40M | $162.04M | $59.94M |
EPS (Diluted) | $0.04 | $0.00 | $0.82 | $0.75 | $0.52 |
Total Assets | Not available | $1.23B | $1.20B | $1.25B | $1.22B |
Total Liabilities | Not available | $298.63M | $249.16M | $269.06M | $273.66M |
Cash & Equivalents | Not available | $113.01M | $116.26M | $128.37M | $94.17M |
Free Cash Flow OCF − CapEx | Not available | $14.87M | $146.40M | $122.37M | $79.51M |
Shares Outstanding | Not available | Not available | 214.54M | Not available | Not available |